Bath & Body Works Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.2% | -4.4% | -5.2% | +0.7% | -2.2% | +0.2% | -1.4% | +3.6% | +1.6% | -2.1% | +3.9% | |
| – | +8.0% | -9.4% | -13.1% | +3.2% | +6.0% | -0.2% | -6.3% | +10.3% | +7.3% | -5.9% | +8.0% | |
| – | +163.1% | -21.1% | -39.9% | -62.8% | +252.9% | -5.6% | -42.8% | -35.2% | +303.8% | -14.0% | -3.2% | |
| – | +163.1% | -21.1% | -39.9% | -62.8% | +252.9% | -5.6% | -42.8% | -35.2% | +303.8% | -14.0% | -3.2% | |
| – | +13.7% | -46.0% | +20.7% | +37.0% | +2.5% | -49.8% | +27.2% | +29.0% | +6.5% | -45.6% | +57.1% | |
| – | -41.1% | +14.6% | +6.0% | +36.5% | -37.7% | +18.4% | +12.4% | +28.0% | -44.1% | +11.9% | +12.9% | |
| – | – | – | – | – | -5.1% | +0.2% | +1.3% | +0.0% | -1.9% | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | -3.8% | -2.7% | -3.3% | +1.0% | -7.1% | +1.2% | +0.5% | +3.5% | -3.5% | -4.0% | +1.9% | |
| – | -8.5% | -5.3% | +22.6% | +5.2% | -21.8% | +5.1% | +0.7% | +19.2% | +2.4% | -13.5% | +24.0% | |
| – | -5.7% | +2.8% | +168.3% | +0.6% | -61.8% | +4.7% | -3.5% | -0.5% | +146.1% | -56.6% | +117.0% | |
| – | -39.4% | +6.1% | +2.0% | +24.1% | -33.7% | +33.7% | +25.4% | +37.7% | -40.5% | +19.8% | +21.4% | |
| – | -2.4% | -2.4% | -9.4% | +0.1% | +0.0% | +0.1% | +0.1% | +0.1% | -7.1% | +0.0% | -6.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.4% | -0.4% | -1.3% | -1.8% | -0.9% | -0.9% | -1.6% | +0.0% | +0.0% | -4.5% | +0.0% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.